Article

APSHO Presents Award for Excellence in Advanced Practice in Oncology

The Mary Pazdur Award was presented during the JADPRO Live Virtual conference.

The Advanced Practitioner Society for Hematology and Oncology (APSHO) has named Christina Cone, DNP, APRN, ANP-BC, AOCNP the recipient of its third annual Mary Pazdur Award for Excellence in Advanced Practice in Oncology. The award was presented during the JADPRO Live Virtual conference, an annual educational meeting for oncology advanced practitioners.

The award was created in honor of Mary Pazdur, RN, MSN, and is given to an advanced practitioner APSHO member who consistently demonstrates exemplary leadership and outstanding contributions to clinical practice, research, and education in the oncology/hematology field, according to the organization.

Cone is a board-certified adult nurse practitioner (ANP) and serves as the Administrative Director of The Preston Robert Tisch Brain Tumor Center (PRTBTC) at the Duke Cancer Institute, one of the largest brain tumor centers in the world. She also serves as the administrative director for the Duke Center for Brain and Spine Metastasis, which focuses on the treatment of solid tumor brain and spine metastases. She was previously the Advanced Practice Provider Team Lead at the PRTBTC, where she had been a nurse practitioner since 2010.

“Christina is a brilliant and inspirational leader, and it is one of the professional pleasures of my life to be able to work so closely with her on a daily basis in our extraordinarily busy oncology program,” said Henry S. Friedman, MD, division chief in the Department of Neurosurgery and Deputy Director of the PRTBTC at Duke, in a prepared statement.

“I truly believe Christina is a remarkable clinician, leader, and educator who impacts the lives of her patients as dramatically as she does the lives of the health-care professionals in the PRTBTC and the Center for Brain and Spine Metastasis,” said Friedman.

Cone obtained a Doctorate in Nursing Practice from East Carolina University in 2016 and a Master of Science in Nursing in the ANP program with a specialty in oncology from the Duke University School of Nursing in 2004. She has been practicing advanced oncology nursing as a board-certified adult nurse practitioner for 15 years.

“Dr. Cone is an advocate for interdisciplinary advanced practice providers (APPs) to practice to the extent of their licensure and education,” said Mary Lou Affronti, DNP, RN, MHSc, ANP, Brain Tumor Center Adult Clinical Director, Brain Tumor Center Nurse Practitioner/Primary Investigator, and Associate Professor at the Duke School of Nursing, in a prepared statement.

“Under her leadership, she has effectively set up independent APP-led clinics where nurse practitioners, physician assistants, and clinical pharmacists can autonomously practice to improve patient care and access,” said Affronti.

Past recipients of the award include Jody Pelusi, PhD, FNP, AOCNP, of HonorHealth Research Institute in Scottsdale, Arizona, and Jeannine Brant, PhD, APRN, AOCN, FAAN, of Billings Clinic in Billings, Montana.

APSHO is accepting nominations for the fourth annual Mary Pazdur Award for Excellence in Advanced Practice, which will be presented at the 2021 JADPRO Live conference. The winner will receive an honorarium and an all-expenses-paid trip to the 2021 conference, as well as recognition at the meeting and in the Journal of the Advanced Practitioner in Oncology.

REFERENCE

Dr. Christina Cone Honored With The Mary Pazdur Award for Excellence in Advanced Practice in Oncology by APSHO [news release]. Lawrenceville, NJ; October 17, 2020: APSHO. Accessed October 19, 2020. https://www.apsho.org/news/531082/The-Mary-Pazdur-Award-for-Excellence-in-Advanced-Practice-in-Oncology-2020-Recipient-Announced.htm

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com